Optiver Holding
PLSE icon

Optiver Holding’s Pulse Biosciences PLSE Stock Holding History

Optiver Holding’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.83K Sell
102
-58
-36% -$1.37K ﹤0.01% 2198
2026
Q1 		$3.45K Sell
160
-136
-46% -$2.51K ﹤0.01% 1593
2025
Q4 		$4.06K Hold
296
– – ﹤0.01% 1520
2025
Q3 		$5.24K Buy
+296
New +$4.68K ﹤0.01% 1704

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Optiver Holding's PLSE Position: Q2 2026 in Review

Optiver Holding reduced its Pulse Biosciences (PLSE) stake by 36% in Q2 2026, selling an estimated $1.37K and leaving 102 shares worth $2.83K. The position accounts for ﹤0.01% of the portfolio, ranked #2198.

Optiver Holding first reported a position in PLSE in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.24K in Q3 2025. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Optiver Holding held 102 shares of Pulse Biosciences worth $2.83K as of Q2 2026.
  • Optiver Holding sold 58 Pulse Biosciences shares in Q2 2026, an estimated $1.37K.
  • Pulse Biosciences made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2198 holding.
  • Optiver Holding first reported a position in Pulse Biosciences in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Pulse Biosciences position peaked at $5.24K in Q3 2025.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.